Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuele Gherardi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|March 14, 2013
MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coinSamuele Gherardi, Emanuele Valli, Daniela Erriquez, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
Cancer Research|February 11, 2010
p53 is a direct transcriptional target of MYCN in neuroblastomaLindi Chen, Nunzio Iraci, Samuele Gherardi, et al.
The Journal of Biological Chemistry|January 31, 2013
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implicationsDaisy Corvetta, Olesya Chayka, Samuele Gherardi, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|February 21, 2017
Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modificationSamuele Gherardi, Doriane Ripoche, Ivan Mikaelian, et al.
Cancer Research|December 3, 2010
A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGFNunzio Iraci, Daniel Diolaiti, Antonella Papa, et al.
Breast Cancer Research and Treatment|September 25, 2021
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypesRomain Teinturier, Razan Abou Ziki, Loay Kassem, et al.
Plos One|October 3, 2012
The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoformsMatteo Bovolenta, Daniela Erriquez, Emanuele Valli, et al.
The Journal of Pathology|February 12, 2017
Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomasRémy Bonnavion, Romain Teinturier, Samuele Gherardi, et al.
Oncogene|December 16, 2020
Men1 disruption in Nkx3.1-deficient mice results in AR<sup>low</sup>/CD44<sup>+</sup> microinvasive carcinoma development with the dysregulated AR pathwayRomain Teinturier, Yakun Luo, Myriam Decaussin-Petrucci, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|March 14, 2013
MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coinSamuele Gherardi, Emanuele Valli, Daniela Erriquez, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
Cancer Research|February 11, 2010
p53 is a direct transcriptional target of MYCN in neuroblastomaLindi Chen, Nunzio Iraci, Samuele Gherardi, et al.
The Journal of Biological Chemistry|January 31, 2013
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implicationsDaisy Corvetta, Olesya Chayka, Samuele Gherardi, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|February 21, 2017
Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modificationSamuele Gherardi, Doriane Ripoche, Ivan Mikaelian, et al.
Cancer Research|December 3, 2010
A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGFNunzio Iraci, Daniel Diolaiti, Antonella Papa, et al.
Breast Cancer Research and Treatment|September 25, 2021
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypesRomain Teinturier, Razan Abou Ziki, Loay Kassem, et al.
Plos One|October 3, 2012
The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoformsMatteo Bovolenta, Daniela Erriquez, Emanuele Valli, et al.
The Journal of Pathology|February 12, 2017
Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomasRémy Bonnavion, Romain Teinturier, Samuele Gherardi, et al.
Oncogene|December 16, 2020
Men1 disruption in Nkx3.1-deficient mice results in AR<sup>low</sup>/CD44<sup>+</sup> microinvasive carcinoma development with the dysregulated AR pathwayRomain Teinturier, Yakun Luo, Myriam Decaussin-Petrucci, et al.
Pageof 2